TY - JOUR
T1 - Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice
AU - Le, Steven Q.
AU - Nestrasil, Igor
AU - Kan, Shih hsin
AU - Egeland, Martin
AU - Cooper, Jonathan D.
AU - Elashoff, David
AU - Guo, Rong
AU - Tolar, Jakub
AU - Yee, Jennifer K.
AU - Dickson, Patricia I.
N1 - Publisher Copyright:
© 2020 AOCS
PY - 2020/11
Y1 - 2020/11
N2 - Mucopolysaccharidosis type I (MPS I) is a lysosomal disease with progressive central nervous system involvement. This study examined the lipid, cholesterol, and myelin basic protein composition of white matter in the corpus callosum of MPS I mice. We studied 50 week-old, male MPS I mice and littermate, heterozygote controls (n = 12 per group). Male MPS I mice showed lower phosphatidylcholine and ether-linked phosphatidylcholine quantities than controls (p < 0.05). Twenty-two phospholipid or ceramide species showed significant differences in percent of total. Regarding specific lipid species, MPS I mice exhibited lower quantities of sphingomyelin 18:1, phosphatidylserine 38:3, and hexosylceramide d18:1(22:1) mH2O than controls. Principal components analyses of polar, ceramide, and hexosylceramide lipids, respectively, showed some separation of MPS I and control mice. We found no significant differences in myelin gene expression, myelin basic protein, or total cholesterol in the MPS I mice versus heterozygous controls. There was a trend toward lower proteolipid protein-1 levels in MPS I mice (p = 0.06). MPS I mice show subtle changes in white matter composition, with an unknown impact on pathogenesis in this model.
AB - Mucopolysaccharidosis type I (MPS I) is a lysosomal disease with progressive central nervous system involvement. This study examined the lipid, cholesterol, and myelin basic protein composition of white matter in the corpus callosum of MPS I mice. We studied 50 week-old, male MPS I mice and littermate, heterozygote controls (n = 12 per group). Male MPS I mice showed lower phosphatidylcholine and ether-linked phosphatidylcholine quantities than controls (p < 0.05). Twenty-two phospholipid or ceramide species showed significant differences in percent of total. Regarding specific lipid species, MPS I mice exhibited lower quantities of sphingomyelin 18:1, phosphatidylserine 38:3, and hexosylceramide d18:1(22:1) mH2O than controls. Principal components analyses of polar, ceramide, and hexosylceramide lipids, respectively, showed some separation of MPS I and control mice. We found no significant differences in myelin gene expression, myelin basic protein, or total cholesterol in the MPS I mice versus heterozygous controls. There was a trend toward lower proteolipid protein-1 levels in MPS I mice (p = 0.06). MPS I mice show subtle changes in white matter composition, with an unknown impact on pathogenesis in this model.
KW - Glycosaminoglycans
KW - Hurler syndrome
KW - Inborn errors of metabolism
KW - Lipidomics
KW - Lysosomal storage disease
UR - http://www.scopus.com/inward/record.url?scp=85086401731&partnerID=8YFLogxK
U2 - 10.1002/lipd.12261
DO - 10.1002/lipd.12261
M3 - Article
C2 - 32537944
AN - SCOPUS:85086401731
SN - 0024-4201
VL - 55
SP - 627
EP - 637
JO - Lipids
JF - Lipids
IS - 6
ER -